ALMR (Alamar Biosciences) FCF Margin %: -80.84% (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ALMR Alamar Biosciences Inc ALMR
8 GF Score
Price $27.07
! 1 Warning Sign
View Full Analysis

What is Alamar Biosciences FCF Margin %?

Alamar Biosciences ALMR +6.62% 8 FCF Margin % is -80.84% as of Dec. 2025. GuruFocus rates ALMR with a GF Score™ of 8/100. The stock has 1 warning sign investors should review. Among 816 Medical Devices & Instruments companies, Alamar Biosciences ranks worse than 83.09% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Alamar Biosciences's Free Cash Flow for the six months ended in Dec. 2025 was $-59.99 Mil. Alamar Biosciences's Revenue for the six months ended in Dec. 2025 was $74.21 Mil. Therefore, Alamar Biosciences's FCF Margin % for the quarter that ended in Dec. 2025 was -80.84%.

As of today, Alamar Biosciences's current FCF Yield % is -3.20%.

The historical rank and industry rank for Alamar Biosciences's FCF Margin % or its related term are showing as below:

ALMR' s FCF Margin % Range Over the Past 10 Years
Min: -233.08   Med: -156.96   Max: -80.84
Current: -80.84

During the past 2 years, the highest FCF Margin % of Alamar Biosciences was -80.84%. The lowest was -233.08%. And the median was -156.96%.

ALMR's FCF Margin % is ranked worse than
83.09% of 816 companies
in the Medical Devices & Instruments industry
Industry Median: -0.56 vs ALMR: -80.84

Alamar Biosciences FCF Margin % Related Terms

Alamar Biosciences FCF Margin % Historical Data

* Premium members only.

The historical data trend for Alamar Biosciences's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Alamar Biosciences FCF Margin % Chart

Alamar Biosciences Annual Data
Trend Dec24 Dec25
FCF Margin %
-233.08 -80.84

Alamar Biosciences Semi-Annual Data
Dec24 Dec25
FCF Margin % -233.08 -80.84

ALMR vs UFPT, BFLY, ENOV: FCF Margin % Comparison

For the Medical Devices subindustry, Alamar Biosciences's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Alamar Biosciences FCF Margin % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Alamar Biosciences's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Alamar Biosciences's FCF Margin % falls into.


ALMR
8GF Score
Alamar Biosciences Inc ALMR
FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Alamar Biosciences FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Alamar Biosciences's FCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-59.992/74.211
=-80.84 %

Alamar Biosciences's FCF Margin for the quarter that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=-59.992/74.211
=-80.84 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of -80.84% mean?
Alamar Biosciences (ALMR) has a FCF Margin % of -80.84% as of Dec. 2025. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Alamar Biosciences and its competitors. According to the industry distribution chart, Alamar Biosciences ranks #678 out of 816 companies in the Medical Devices & Instruments industry, placing it in the top 83.1%.
Is Alamar Biosciences' FCF Margin % too high?
Alamar Biosciences' current FCF Margin % is -80.84%. Based on the distribution chart, Alamar Biosciences ranks #678 out of 816 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Alamar Biosciences has a GF Score™ of 8/100, reflecting its overall financial health beyond just this single metric.
How does Alamar Biosciences' FCF Margin % compare to UFPT and BFLY?
According to the Medical Devices & Instruments industry distribution chart, Alamar Biosciences ranks #678 out of 816 companies for FCF Margin %. This places Alamar Biosciences in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Medical Devices & Instruments company?
A good FCF Margin % depends on the Medical Devices & Instruments industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Alamar Biosciences and its competitors. Alamar Biosciences's current FCF Margin % is -80.84%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alamar Biosciences stock overvalued right now?
Alamar Biosciences (ALMR) has a current FCF Margin % of -80.84%. The current FCF Margin % is -80.84%. Alamar Biosciences' overall GF Score™ is 8/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Alamar Biosciences (ALMR), the current FCF Margin % is -80.84% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Alamar Biosciences Business Description

Address 47071 Bayside Parkway, Fremont, CA, USA, 94538
Alamar Biosciences Inc is a proteomics company engaged in protein detection and analysis. The company has developed its own NULISA (NUcleic Acid Linked Immuno-Sandwich Assay) technology as the foundation of its Precision Proteomics platform enabling the detection and quantification of protein biomarkers in a single sample with ultra-high sensitivity and high specificity, even from very small volumes of biofluid. The company operates in single segment and focuses on developing a good sensitive proteomic liquid biopsy platform and sells instruments, consumables, and services based on this platform to enable early detection of diseases. The products of the company includes NULISAseq Panels, NULISAqpcr Assays, and others.
8GF Score

Get the complete analysis for ALMR

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$27.07
Price